Synonyms: LYT-100
Compound class:
Synthetic organic
Comment: Deupirfenidone is a deuterated version of the anti-fibrotic drug pirfenidone. Like its parent it inhibits production of pro-inflammatory mediators, including interleukin-6 (IL-6), tumor necrosis factor α (TNFα) and transforming growth factor β (TGFβ).
|
|
No information available. |
Summary of Clinical Use ![]() |
LYT-100 has been entered into clinical studies to evaluate its ability to reduce lung fibrosis in idiopathic pulmonary fibrosis (IPF) and long COVID-19. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04652518 | LYT-100 in Post-acute COVID-19 Respiratory Disease | Phase 2 Interventional | PureTech | ||
NCT05321420 | LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 Interventional | PureTech |